TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10530259

Group type: EXPERIMENTAL
Intervention: Single visit treatment without calcium hydroxide
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Single visit treatment with calcium hydroxide
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Multivisit treatment with calcium hydroxide
Number of subjects: 3

Group type: COMPARATOR
Intervention: Multivisit treatment without calcium hydroxide
Number of subjects: 3
Study: 8821109

Group type: EXPERIMENTAL
Intervention: Shielded 3 ml safety syringe and components of a needleless IV system
Number of subjects: 47
Study: 2149543

Group type: EXPERIMENTAL
Intervention: Paracetamol-sobrerol combination
Number of subjects: 287

Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 287
Study: 7362451

Group type: EXPERIMENTAL
Intervention: T3 treatment (200 micrograms/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 15
Study: 31131635

Group type: EXPERIMENTAL
Intervention: Anti-smoking campaign exposure (Give me one lung cancer campaign)
Number of subjects: 207
Study: 30150326

Group type: EXPERIMENTAL
Intervention: Basic app
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Advanced app
Number of subjects: 163

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 163
Study: 28916975

Group type: EXPERIMENTAL
Intervention: Flaxseed oil supplementation (1000 mg n‐3 fatty acid containing 400 mg α‐Linolenic acid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25662205

Group type: EXPERIMENTAL
Intervention: Pentax laryngoscope
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Truview laryngoscope
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: GlideScope laryngoscope
Number of subjects: 141

Group type: COMPARATOR
Intervention: Miller laryngoscope
Number of subjects: 141
Study: 23638784

Group type: EXPERIMENTAL
Intervention: Progressive MCS (ankle pressure: 8‐12 mmHg; calf pressure: 21‐25 mmHg)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Degressive MCS (ankle pressure: 24‐28 mmHg; calf pressure: 14‐18 mmHg)
Number of subjects: 220
Study: 21174486

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone (5 mg)
Number of subjects: 41
Study: 19515734

Group type: EXPERIMENTAL
Intervention: 1.8 g EPA+DHA/d
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 0.4 g EPA+DHA/d
Number of subjects: 111

Group type: COMPARATOR
Intervention: 4.0 g high-oleic acid sunflower oil (HOSF)/d
Number of subjects: 111
Study: 17894535

Group type: EXPERIMENTAL
Intervention: Tobramycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taurolidine
Number of subjects: 0
Study: 15234278

Group type: EXPERIMENTAL
Intervention: Super blue-green algae (SBGA) capsules
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11691500

Group type: EXPERIMENTAL
Intervention: Intensive hypoglycemic regimen (diet modification plus troglitazone)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conservative hypoglycemic regimen (diet modification plus placebo)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both interventions (intensive and conservative)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patients without glycemic improvement
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Improved glycemic control
Number of subjects: 40
Study: 9405904

Group type: EXPERIMENTAL
Intervention: Baseline proinsulin levels
Number of subjects: 1193

Group type: EXPERIMENTAL
Intervention: Age, male sex, fasting and 2-h glucose levels
Number of subjects: 1193

Group type: COMPARATOR
Intervention: Waist-to-hip ratio and BMI
Number of subjects: 1193

Group type: COMPARATOR
Intervention: Incidence of NIDDM
Number of subjects: 1193
Study: 7950208

Group type: EXPERIMENTAL
Intervention: Baoyuan Dahuang Decoction
Number of subjects: 56

Group type: COMPARATOR
Intervention: Comprehensive treatment of Western medicine (Control)
Number of subjects: 56
Study: 3294888

Group type: EXPERIMENTAL
Intervention: Chlamydiazyme (CZ)
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: MicroTrak (MT)
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Culture system
Number of subjects: 1059
Study: 2232019

Group type: EXPERIMENTAL
Intervention: Child and Parent Group
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Child Group
Number of subjects: 3

Group type: COMPARATOR
Intervention: Nonspecific Control Group
Number of subjects: 3
Study: 1094819

Group type: EXPERIMENTAL
Intervention: 10 mg of oral isosorbide dinitrate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30721780

Group type: COMPARATOR
Intervention: Rigid instruments
Number of subjects: 16

Group type: COMPARATOR
Intervention: da Vinci system
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Steerable instrument
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Steerable instruments
Number of subjects: 16
Study: 28346472

Group type: EXPERIMENTAL
Intervention: Reassuring information with a simple non‐threatening explanation for LBP (functional‐disturbance model)
Number of subjects: 505
Study: 25813525

Group type: EXPERIMENTAL
Intervention: Quartile 4 (Q4) of plasma 25(OH)D
Number of subjects: 548

Group type: COMPARATOR
Intervention: Mean plasma 25(OH)D
Number of subjects: 548
Study: 23579183

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) applied over the hand motor area
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) applied over the leg motor area
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 16
Study: 21273184

Group type: EXPERIMENTAL
Intervention: Clinician-assisted computer-based (CAC) psychological treatment
Number of subjects: 97

Group type: COMPARATOR
Intervention: Brief intervention (BI)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Therapist-delivered treatment
Number of subjects: 97
Study: 19296875

Group type: EXPERIMENTAL
Intervention: Plant sterol-enriched yoghurt drink (2 g/d)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fish oil n-3 LC-PUFA capsules (2 g/d)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combination of plant sterols and fish oil n-3 LC-PUFA
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control yoghurt drink and control capsules
Number of subjects: 200
Study: 16500071

Group type: EXPERIMENTAL
Intervention: Individual psychosocial support by specially trained oncology nurses (INS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Individual psychosocial support by psychologists (IPS)
Number of subjects: 120
Study: 15313950

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 199

Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 11557642

Group type: EXPERIMENTAL
Intervention: E(2) administration (17beta‐estradiol, transdermal patch, 0.1 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: E(2) with P(4) administration (vaginal gel, 90 mg P(4) twice per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: GnRH analog alone
Number of subjects: 12
Study: 9370073

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy followed by radiation therapy
Number of subjects: 0
Study: 8394956

Group type: EXPERIMENTAL
Intervention: Lithium carbonate therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AA meeting attendance
Number of subjects: 0
Study: 3621549

Group type: EXPERIMENTAL
Intervention: Topical dermal anaesthesia (EMLA)
Number of subjects: 21
Study: 31237242

Group type: EXPERIMENTAL
Intervention: iQuit Mindfully (MBAT + between-session text messages)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Mindfulness-Based Addiction Treatment (MBAT)
Number of subjects: 71
Study: 28554988

Group type: EXPERIMENTAL
Intervention: Garlic powder (twice daily for 3 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablets (twice daily for 3 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Garlic powder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Garlic powder and Placebo
Number of subjects: 0
Study: 25453396

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU daily)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 23313040

Group type: EXPERIMENTAL
Intervention: Transcutaneous peroneal (fibular) nerve stimulation neuroprosthesis for 3 months
Number of subjects: 10
Study: 22019965

Group type: EXPERIMENTAL
Intervention: Postmenopausal osteoporosis group
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nonosteoporotic control group
Number of subjects: 26
Study: 18430848

Group type: EXPERIMENTAL
Intervention: Whole milk
Number of subjects: 215

Group type: COMPARATOR
Intervention: VoLumen
Number of subjects: 215
Study: 16436459

Group type: EXPERIMENTAL
Intervention: Mailed intervention consisting of a letter with psychological score feedback and a self-help sheet
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 233
Study: 12913036

Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 5153

Group type: EXPERIMENTAL
Intervention: Moderate physical activity
Number of subjects: 5153

Group type: COMPARATOR
Intervention: Adjustment for BMI and resting heart rate (HR)
Number of subjects: 5153
Study: 10473841

Group type: EXPERIMENTAL
Intervention: Toluene (1.5 mg/min, 4 mg/min), Trichloroethylene (1.5 mg/min, 4 mg/min), n-Hexane (0.3 mg/min, 1.0 mg/min) administered via gastrointestinal application for 60 min.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Toluene, Trichloroethylene, n-Hexane exposure via gastrointestinal application.
Number of subjects: 8
Study: 8595536

Group type: EXPERIMENTAL
Intervention: Mizolastine 10 mg
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mizolastine 15 mg
Number of subjects: 494

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 494
Study: 1928028

Group type: EXPERIMENTAL
Intervention: HIV‐antibody positive cocaine addicts
Number of subjects: 44

Group type: COMPARATOR
Intervention: HIV‐seronegative cocaine addicts
Number of subjects: 44
Study: 6351590

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 29022755

Group type: EXPERIMENTAL
Intervention: ADAM zolmitriptan 3.8 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26518044

Group type: EXPERIMENTAL
Intervention: Bivalent HPV vaccine targeting HPV-16 and HPV-18
Number of subjects: 0
Study: 24118561

Group type: EXPERIMENTAL
Intervention: Proprietary program for increasing self-efficacy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 22654512

Group type: EXPERIMENTAL
Intervention: Multisensory exercises (GM)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Strength training (GS)
Number of subjects: 46
Study: 20461002

Group type: EXPERIMENTAL
Intervention: Naloxone 200 microg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Naloxone 400 microg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Naloxone 25 microg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Naloxone 100 microg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 18661867

Group type: EXPERIMENTAL
Intervention: Multiple-unit polystyrene microparticles (50% indomethacin load)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial Microcid immediate-release capsules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimized microparticles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indocap-SR capsules
Number of subjects: 0
Study: 16280946

Group type: EXPERIMENTAL
Intervention: Directly receiving a free helmet in the ED
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Voucher intervention (receiving a voucher for a free helmet)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (usual care with verbal counseling)
Number of subjects: 200
Study: 12558777

Group type: EXPERIMENTAL
Intervention: B-domain deleted recombinant factor VIII (BDDrFVIII)
Number of subjects: 218
Study: 9459225

Group type: EXPERIMENTAL
Intervention: Lidocaine bolus (1.5 mg/kg) and infusion (3 mg/min, unless weight <70 kg, then 2 mg/min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 40
Study: 8546286

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway in the Trendelenburg position
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway in the lithotomy position
Number of subjects: 90

Group type: COMPARATOR
Intervention: Laryngeal mask airway in the supine position
Number of subjects: 90
Study: 2403850

Group type: EXPERIMENTAL
Intervention: succinylcholine 0.15 mg.kg‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: succinylcholine 0.25 mg.kg‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: succinylcholine 0.50 mg.kg‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: succinylcholine 1.00 mg.kg‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: succinylcholine (various doses)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: succinylcholine
Number of subjects: 20
Study: 734314

Group type: EXPERIMENTAL
Intervention: Indomethacin, 100 mg orally
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prednisolone, 5 mg
Number of subjects: 24
Study: 31031072

Group type: EXPERIMENTAL
Intervention: Prior need for advanced techniques (ultrasound guidance or external jugular vein catheterization)
Number of subjects: 600

Group type: COMPARATOR
Intervention: No prior difficulty
Number of subjects: 600
Study: 26797810

Group type: EXPERIMENTAL
Intervention: Hydronidone 15-120 mg single dose
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydronidone 90 and 120 mg thrice daily for 7 days
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydronidone 60 mg thrice daily for 28 days
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydronidone with food
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydronidone (all doses)
Number of subjects: 88
Study: 25385061

Group type: EXPERIMENTAL
Intervention: ketorolac tromethamine 0.4% (Acular LS, Allergan)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: nepafenac 0.1% (Nevanac, Alcon)
Number of subjects: 126

Group type: COMPARATOR
Intervention: topical artificial tear substitute (placebo)
Number of subjects: 126
Study: 23632035

Group type: EXPERIMENTAL
Intervention: Thylakoids added to a high carbohydrate meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (high carbohydrate meal without thylakoids)
Number of subjects: 20
Study: 21329821

Group type: EXPERIMENTAL
Intervention: 15% EDTA
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 10% citric acid
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 10% sodium citrate
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 5% malic acid
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 5% acetic acid
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: apple vinegar
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (no irrigation)
Number of subjects: 35
Study: 19470311

Group type: EXPERIMENTAL
Intervention: Immediate Treatment group (7 clinic visits across 18 months)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Delayed Treatment group (9 clinic visits across 24 months)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Late Completers (n=39)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Withdrawals
Number of subjects: 108
Study: 17309139

Group type: COMPARATOR
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: T-tube
Number of subjects: 136
Study: 15570076

Group type: EXPERIMENTAL
Intervention: FOLFOX4 (LV and FU plus oxaliplatin 85 mg/m2 IV over 2 hours on day 1)
Number of subjects: 214

Group type: COMPARATOR
Intervention: LV5FU2 (LV 200 mg/m2 IV and FU 400 mg/m2 IV bolus, followed by FU 600 mg/m2 IV over 22 hours on days 1 and 2)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: FOLFOX4 (among patients who crossed over from LV5FU2)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Grade 3/4 toxicities for FOLFOX4
Number of subjects: 214

Group type: COMPARATOR
Intervention: Grade 3/4 toxicities for LV5FU2
Number of subjects: 214
Study: 11234669

Group type: EXPERIMENTAL
Intervention: Tinzaparin (175 anti‐Xa IU/kg) administered subcutaneously once daily for 10 days
Number of subjects: 30
Study: 9087473

Group type: EXPERIMENTAL
Intervention: Alendronate (dose higher than 1 mg per day)
Number of subjects: 1602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1602

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 1602
Study: 7655702

Group type: EXPERIMENTAL
Intervention: Regular treatment with beta-agonists (unspecified dosage and duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: As-needed beta-agonists (unspecified dosage and duration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenoterol (unspecified dosage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salbutamol (unspecified dosage)
Number of subjects: 0
Study: 1972850

Group type: EXPERIMENTAL
Intervention: roxithromycin 300 mg once a day
Number of subjects: 87

Group type: COMPARATOR
Intervention: erythromycin 500 mg twice a day
Number of subjects: 87
Study: 524621

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Testosterone enanthate (TE)
Number of subjects: 0
Study: 31570258

Group type: EXPERIMENTAL
Intervention: ACURATE neo TAVR system
Number of subjects: 739

Group type: COMPARATOR
Intervention: SAPIEN 3 TAVR system
Number of subjects: 739
Study: 28702451

Group type: EXPERIMENTAL
Intervention: Stabilization in prone (SIP)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Stabilization in supine (SIS)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combination of prone and supine (SIPS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: All groups (SIP, SIS, SIPS)
Number of subjects: 56
Study: 24633458

Group type: EXPERIMENTAL
Intervention: Short-segmental fixation in situ with decompression and bone grafting
Number of subjects: 40

Group type: COMPARATOR
Intervention: Long-segmental fixation with sufficient decompression and short-segmental fusion
Number of subjects: 40
Study: 22085706

Group type: EXPERIMENTAL
Intervention: Internet-based weight loss interventions
Number of subjects: 352
Study: 21062180

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no TMS)
Number of subjects: 20
Study: 19025625

Group type: EXPERIMENTAL
Intervention: Dynamic arterial line pressure (DALP) based prescription of Qb (300-500 mL/min)
Number of subjects: 72
Study: 16189075

Group type: EXPERIMENTAL
Intervention: Four-drug regimen (trimethoprim, sulfamethoxazole, doxycycline, and chloramphenicol)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Three-drug regimen (trimethoprim-sulfamethoxazole and doxycycline)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Four-drug regimen
Number of subjects: 180

Group type: COMPARATOR
Intervention: Three-drug regimen
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Duration of oral therapy
Number of subjects: 180
Study: 12651645

Group type: EXPERIMENTAL
Intervention: Clonidine 5 micro g/kg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 10651656

Group type: EXPERIMENTAL
Intervention: Pentasa 1 g sachet (unit dose, microgranules in a foil bag)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pentasa 500 mg tablets (2 x 500 mg)
Number of subjects: 8
Study: 7733059

Group type: EXPERIMENTAL
Intervention: Xylitol gum
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sorbitol gum
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Xylitol-sorbitol mixture I (3:2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Xylitol-sorbitol mixture II (4:1)
Number of subjects: 60
Study: 2254831

Group type: EXPERIMENTAL
Intervention: 0.04% CHX daily home marginal irrigation + 0.12% CHX professional irrigation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Water daily home marginal irrigation + 0.12% CHX professional irrigation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Water daily home marginal irrigation + water professional irrigation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 6104554

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg 3 times a day)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg twice daily)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg 3 times a day)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg 3 times a day)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 30941887

Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) with nutrition education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 28319515

Group type: EXPERIMENTAL
Intervention: Smoking cessation program (counseling session, varenicline, educational pamphlet, fax referral to quitline)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Brief advice and self-referral to quitline
Number of subjects: 296
Study: 26152568

Group type: EXPERIMENTAL
Intervention: Multifaceted feedback strategy (extensive monthly feedback reports, outreach visits, quality improvement team)
Number of subjects: 67237

Group type: COMPARATOR
Intervention: Limited quarterly feedback reports (control group)
Number of subjects: 67237
Study: 24187116

Group type: EXPERIMENTAL
Intervention: Postnatal nurse home visiting intervention (3 to 7 contacts between 3 and 12 weeks after birth)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 549
Study: 21890092

Group type: EXPERIMENTAL
Intervention: Nesiritide infusions
Number of subjects: 911

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 911
Study: 19218044

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA), 40 mg twice daily for 2 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study: 17374171

Group type: EXPERIMENTAL
Intervention: Cycling intervention (strengthening and cardiorespiratory endurance phases)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no cycling)
Number of subjects: 60